Announced details
Development of cosmetics and supplements; research and development in the life sciences
A business relationship in which アドバンスト・メディカル・ケア has adopted and uses FRONTEO’s KIBIT Amanogawa. Capital and personnel relationships: not disclosed.
Head office: Minato-ku, Tokyo; President and Representative Director: Furukawa Tetsuya (古川哲也). The company provides medical service corporation businesses, including operational support for Tokyo Midtown Clinic, clinic management support, cosmetics and supplement businesses, research and development using medical examination data, and health services and products.
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
PubMed (the biomedical and life sciences literature database of the U.S. National Library of Medicine’s National Center for Biotechnology Information)
| Item | Details |
|---|---|
| Names of Products / Services Covered | KIBIT Amanogawa (KIBIT Amanogawa) |
| Counterparty | アドバンスト・メディカル・ケア Co., Ltd. |
| Counterparty overview | Head office: Minato-ku, Tokyo; President and Representative Director: Furukawa Tetsuya (古川哲也). The company provides medical service corporation businesses, including operational support for Tokyo Midtown Clinic, clinic management support, cosmetics and supplement businesses, research and development using medical examination data, and health services and products. |
| Relationship with the Company | A business relationship in which アドバンスト・メディカル・ケア has adopted and uses FRONTEO’s KIBIT Amanogawa. Capital and personnel relationships: not disclosed. |
| Launch date | March 2026 (already implemented) |
| Applicable area | Development of cosmetics and supplements; research and development in the life sciences |
| Source | PubMed (the biomedical and life sciences literature database of the U.S. National Library of Medicine’s National Center for Biotechnology Information) |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.As the importance of demonstrating scientific evidence in cosmetics and supplement development increases, the aim is to efficiently search the vast body of medical literature for new insights and hypotheses and identify new relationships between ingredients and their effects.